Isomorphic Labs, a Deepmind spin-off focused on drug discovery, is getting ready for its first clinical trials with drugs designed using AlphaFold-based AI models.<br /> The article Isomorphic Labs prepares for its first human trials with drugs designed by AlphaFold appeared first on THE DECODER. [...]
Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says doubles AlphaFold 3's accuracy f [...]
Isomorphic Labs, the AI drug research company led by DeepMind co-founder Demis Hassabis, has closed a $2.1 billion Series B round led by Thrive Capital. The funding will go toward expanding its in-hou [...]
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. “We’ll hopefully [...]
Endor Labs, the application security startup backed by more than $208 million in venture funding, today launched AURI, a platform that embeds real-time security intelligence directly into the AI codin [...]
An Australian AI consultant used ChatGPT, AlphaFold, and Grok to find a possible treatment for his dog Rosie's incurable cancer. The story went viral after high-profile AI executives like OpenAI& [...]
Artificial intelligence agents powered by the world's most advanced language models routinely fail to complete even straightforward professional tasks on their own, according to groundbreaking re [...]
John Jumper, the Google DeepMind vice president who won the 2024 Nobel Prize in Chemistry for creating AlphaFold, is leaving the company after nearly nine years to join Anthropic. Jumper announced the [...]